Universal Health Services, Inc. Financial Ratios — UHS Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Return on Common Equity (%)	17.72	16.25	15.8	14.51	15.86	14.85	14.68	13.99	13.9	14.89	14.85	10.28	10.77	16.12	19.38
Return on Assets (%)	5.24	5.59	6.19	6.31	7.32	7.05	7.14	7.08	7.11	7.51	7.46	5.08	5.23	8.03	9.93
Return on Capital (%)	7.2	7.19	7.66	7.51	8.48	8.36	8.88	9.05	9.19	9.51	9.5	6.84	7.26	10.25	12.31
Return on Invested Capital (%)	9.29	9.25	8.9	9.74	10.53	9.78	9.66	9.68	9.68	9.96	9.58	6.83	7.79	11.06	12.35
Gross Margin (%)	88.08	88.51	88.86	89.08	89.23	89.44	89.38	89.15	89	88.86	88.71	89	89.27	89.97	90.45
EBITDA Margin (%)	17.65	17.96	17.53	17.64	18.16	17.33	16.6	15.12	15	16.17	15	11.83	12.21	14.32	15.05
Operating Margin (%)	13.27	13.53	12.95	13.06	13.75	13.07	12.3	10.91	10.69	11.75	10.78	7.49	8.23	10.63	11.48
Incremental Operating Margin (%)	21.04	22.16	3.13	13.99	20.52	4.5	0.64	-28.95	6.71	78.86	0.44	-47.48	19.47	32.76	20.31
Pretax Margin (%)	10.3	10.97	11.8	11.33	12.67	11.84	10.9	9.6	9.37	10.83	10.23	6.46	6.58	9.46	11.36
Profit Margin (%)	5.89	6.37	6.93	6.65	7.53	7.19	7.23	7.24	7.16	8.17	7.84	5.04	5.03	7.22	8.57
Net Income to Common Margin (%)	5.89	6.37	6.93	6.65	7.53	7.19	7.23	7.24	7.16	8.17	7.84	5.04	5.03	7.22	8.57
Effective Tax Rate (%)	35.54	35.96	36.27	34.92	34.49	35.39	32.04	22.87	22.39	23.9	23.64	24.16	23.51	22.35	23.37
Dvd Payout Ratio (%)	3.9	10.92	3.28	4.46	4.82	4.91	4.83	4.58	6.31	1.8	6.7	9.16	7.7	4.51	3.34
Sustainable Growth Rate (%)	17.03	14.47	15.28	13.86	15.09	14.12	13.97	13.35	13.02	14.62	13.86	9.34	9.94	15.39	18.73

Credit (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Total Debt	3,654	3,730	3,309	3,279	3,431	4,136	4,040	3,999	4,311	4,194	4,559	5,271	5,367	4,955	5,167
ST Debt	2	3	99	68	63	106	546	63	144	392	113	149	198	115	821
LT Debt	3,651	3,727	3,210	3,210	3,369	4,030	3,494	3,935	4,167	3,803	4,447	5,122	5,168	4,841	4,345
Total Debt/EBITDA	3.06	2.98	2.56	2.27	2.09	2.44	2.34	2.46	2.53	2.24	2.4	3.32	3.08	2.19	1.98
Net Debt/EBITDA	3.03	2.96	2.55	2.24	2.05	2.42	2.29	2.39	2.3	1.41	2.15	2.97	2.75	1.93	1.77
Total Debt/EBIT	4.07	3.96	3.47	3.06	2.76	3.24	3.16	3.4	3.55	3.09	3.34	5.25	4.57	2.95	2.59
Net Debt/EBIT	4.03	3.94	3.45	3.03	2.71	3.21	3.1	3.31	3.23	1.94	2.99	4.69	4.08	2.6	2.31
EBITDA to Interest Expense	7.25	9.53	11.65	14.51	17.03	15.6	12.9	11.05	10.49	17.58	22.66	12.49	8.44	12.42	17.16
EBITDA-CapEx/Interest Expense	5.34	2.74	8.3	6.13	7.56	4.95	8.35	5.54	6.46	10.68	12.44	6.71	4.84	7.25	10.33
EBIT to Interest Expense	5.46	7.17	8.6	10.75	12.9	11.76	9.56	7.98	7.47	12.78	16.29	7.91	5.69	9.21	13.1
Interest Expense	164	131	111	100	96	109	134	147	163	106	84	127	207	183	152
Common Equity/Total Assets	32.55	36.14	42.11	44.75	47.5	47.42	49.75	51.43	50.86	50.07	50.44	48.42	48.68	50.95	51.48
Long-Term Debt/Equity (%)	142.33	124.24	91.23	79.65	74.01	87.48	69.08	71.94	74.63	59.35	71.74	85.8	83.33	71.58	58.64
Long-Term Debt/Capital (%)	56.89	53.4	45.35	42.3	40.58	44.28	36.93	39.86	40.36	34.47	39.44	43.21	42.3	38.96	32.69
Long-Term Debt/Total Assets (%)	47.64	45.45	38.62	35.77	35.03	39.06	32.47	34.93	35.71	28.22	33.96	37.96	37	33.45	27.98
Total Debt/Equity (%)	142.43	124.32	94.05	81.34	75.39	89.78	79.87	73.1	77.21	65.47	73.56	88.3	86.53	73.27	69.73
Total Debt/Capital (%)	56.93	53.44	46.75	43.2	41.34	45.44	42.69	40.5	41.75	38.02	40.45	44.46	43.92	39.88	38.86
Total Debt/Total Assets (%)	47.67	45.48	39.81	36.53	35.69	40.09	37.54	35.49	36.94	31.12	34.82	39.06	38.42	34.25	33.27
Net Debt to Equity	140.82	123.54	93.56	80.54	74.04	89.05	78.4	71.18	70.26	41.08	65.74	78.81	77.28	64.74	62.28
Net Debt/Capital (%)	56.65	53.28	46.62	42.96	40.9	45.24	42.24	39.86	38.22	26.83	36.52	40.04	39.61	35.6	35.08
EBITDA	1,193	1,250	1,292	1,447	1,642	1,693	1,728	1,628	1,706	1,869	1,896	1,585	1,743	2,267	2,613
EBITDA-CapEx	878	359	921	611	729	537	1,119	817	1,051	1,135	1,041	851	1,000	1,323	1,573
Operating Income (Loss)	897	942	954	1,072	1,244	1,276	1,280	1,175	1,216	1,358	1,363	1,004	1,175	1,682	1,994

Liquidity (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Cash Ratio	0.05	0.03	0.02	0.03	0.06	0.03	0.04	0.07	0.04	0.49	0.06	0.05	0.06	0.06	0.04
Current Ratio	1.63	1.57	1.35	1.37	1.56	1.28	0.97	1.34	1.23	1.32	1.14	1.33	1.4	1.27	1.05
Quick Ratio	1.21	1.22	1.07	1.11	1.24	1.12	0.85	1.11	1.04	1.19	0.94	1.11	1.17	1.04	0.85
CFO/Avg Current Liab	0.85	0.92	0.91	0.92	0.94	1.1	0.79	0.77	0.96	1.17	0.4	0.51	0.65	0.98	0.68
Common Equity/Total Assets	32.55	36.14	42.11	44.75	47.5	47.42	49.75	51.43	50.86	50.07	50.44	48.42	48.68	50.95	51.48
Long-Term Debt/Equity (%)	142.33	124.24	91.23	79.65	74.01	87.48	69.08	71.94	74.63	59.35	71.74	85.8	83.33	71.58	58.64
Long-Term Debt/Capital (%)	56.89	53.4	45.35	42.3	40.58	44.28	36.93	39.86	40.36	34.47	39.44	43.21	42.3	38.96	32.69
Long-Term Debt/Total Assets (%)	47.64	45.45	38.62	35.77	35.03	39.06	32.47	34.93	35.71	28.22	33.96	37.96	37	33.45	27.98
Total Debt/Equity (%)	142.43	124.32	94.05	81.34	75.39	89.78	79.87	73.1	77.21	65.47	73.56	88.3	86.53	73.27	69.73
Total Debt/Capital (%)	56.93	53.44	46.75	43.2	41.34	45.44	42.69	40.5	41.75	38.02	40.45	44.46	43.92	39.88	38.86
Total Debt/Total Assets (%)	47.67	45.48	39.81	36.53	35.69	40.09	37.54	35.49	36.94	31.12	34.82	39.06	38.42	34.25	33.27
CFO/Total Liabilities	13.94	15.37	18.45	20.95	21.1	23.36	21.87	22	23.64	33.38	12.82	13.24	16.33	26.82	22.97
CFO/CapEx	2.26	0.9	2.38	1.24	1.17	1.15	2.05	1.57	2.19	3.21	1.03	1.36	1.71	2.19	1.79
Altman's Z-Score	3.19	3.41	4.01	4.48	4.77	4.34	4.32	4.27	4.35	3.75	3.86	3.6	3.67	4.01	4.09

Working Capital (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Accounts Receivable Turnover	7.48	6.83	6.75	6.84	7	7.12	7.08	7.16	7.41	7.03	7.27	7.12	6.71	7.17	7.27
Days Sales Outstanding	48.8	53.4	54.1	53.37	52.17	51.24	51.55	51.01	49.25	51.94	50.17	51.27	54.38	50.92	50.24
Inventory Turnover	8.43	8.17	8.18	8.53	8.69	8.54	8.45	8.22	8.12	7.35	7.18	6.93	7.04	7.25	7.32
Days Inventory Outstanding	43.3	44.68	44.63	42.77	42	42.72	43.19	44.41	44.93	49.63	50.8	52.65	51.85	50.34	49.84
Accounts Payable Turnover	3.36	3.38	3.14	2.94	2.8	2.58	2.53	2.66	2.83	2.59	2.35	2.29	2.45	2.56	2.42
Accounts Payable Turnover Days	108.54	108.13	116.06	124.1	130.59	141.33	144.19	137.2	128.98	140.82	155.43	159.1	149.04	142.86	151.03
Cash Conversion Cycle	-16.45	-10.04	-17.33	-27.95	-36.42	-47.38	-49.45	-41.79	-34.79	-39.25	-54.46	-55.18	-42.81	-41.6	-50.95
Inventory to Cash Days	5.5	8.72	9.47	10.61	10.17	8.52	8.36	6.6	4.32	2.31	-0.63	-1.38	2.53	0.58	0.4
Inventories	97	99	102	108	116	125	136	148	160	190	207	219	217	221	232
Raw Materials	97	99	102	108	116	125	136	148	160	190	207	219	217	221	232
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Market Capitalization	3,777	4,681	7,966	10,995	11,805	10,341	10,842	10,872	12,734	11,696	10,699	10,302	10,567	11,941	13,862
- Cash & Cash Equivalents	41	23	17	32	61	34	74	105	61	1,224	115	103	119	126	138
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	269	287	268	295	302	74	69	81	79	89	109	49	53	97	134
+ Total Debt	3,654	3,730	3,309	3,279	3,431	4,136	4,040	3,999	4,311	4,194	4,559	5,271	5,367	4,955	5,167
Enterprise Value	7,659	8,675	11,526	14,537	15,477	14,517	14,876	14,846	17,062	14,755	15,252	15,520	15,867	16,867	19,024
Total Capital	6,418	6,980	7,078	7,590	8,301	9,102	9,463	9,874	10,324	11,032	11,273	11,855	12,219	12,425	13,293
Total Debt/Capital (%)	56.93	53.44	46.75	43.2	41.34	45.44	42.69	40.5	41.75	38.02	40.45	44.46	43.92	39.88	38.86
Total Debt / EV	0.48	0.43	0.29	0.23	0.22	0.28	0.27	0.27	0.25	0.28	0.3	0.34	0.34	0.29	0.27
EV/Sales	1.13	1.25	1.56	1.77	1.71	1.49	1.43	1.38	1.5	1.28	1.21	1.16	1.11	1.07	1.1
EV/EBITDA	6.42	6.94	8.92	10.04	9.42	8.58	8.61	9.12	10	7.9	8.04	9.79	9.1	7.44	7.28
EV/EBIT	8.54	9.21	12.08	13.57	12.45	11.38	11.62	12.63	14.03	10.86	11.19	15.46	13.5	10.03	9.54
EV/Cash Flow to Firm	9.38	9.82	12.07	13.21	13.68	10.34	11.11	10.69	10.9	6.04	16.1	14.21	11.13	7.64	9.6
EV/Free Cash Flow to Firm	6.77	4.89	8.69	7.51	7.57	5.67	7.64	6.75	7.68	4.65	8.46	8.5	7.32	5.35	6.3
Diluted Market Cap	3,829	4,724	8,074	11,187	12,032	10,466	10,918	10,928	12,774	11,768	10,852	10,402	10,690	12,182	14,054
Diluted Enterprise Value	7,711	8,718	11,634	14,728	15,704	14,642	14,953	14,902	17,102	14,827	15,404	15,620	15,990	17,108	19,216
EV per Share	78.8	89.6	117.58	147.09	156.66	149.34	155.53	159.17	192.22	173.47	184.83	212.25	228.9	253.44	299.21
TTM Sales	6,760	6,961	7,368	8,205	9,043	9,766	10,410	10,772	11,378	11,559	12,642	13,399	14,282	15,828	17,365
TTM EBITDA	1,193	1,250	1,292	1,447	1,642	1,693	1,728	1,628	1,706	1,869	1,896	1,585	1,743	2,267	2,613
TTM Operating Income	897	942	954	1,072	1,244	1,276	1,280	1,175	1,216	1,358	1,363	1,004	1,175	1,682	1,994
TTM Cash Flow to Firm	817	883	955	1,101	1,131	1,404	1,339	1,388	1,565	2,441	948	1,092	1,426	2,209	1,981
TTM Free Cash Flow to Firm	1,132	1,774	1,326	1,937	2,044	2,559	1,948	2,200	2,220	3,175	1,803	1,826	2,169	3,153	3,021

Multiples (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Price/Free Cash Flow	3.73	2.8	6.43	5.98	6.07	4.2	5.88	5.24	6.1	3.8	6.24	6.01	5.32	4.05	4.84
EV/EBIT	8.54	9.21	12.08	13.57	12.45	11.38	11.62	12.63	14.03	10.86	11.19	15.46	13.5	10.03	9.54
Enterprise Value	7,659	8,675	11,526	14,537	15,477	14,517	14,876	14,846	17,062	14,755	15,252	15,520	15,867	16,867	19,024
Low Price	31.35	36.37	48.94	73.06	101.2	99.72	95.26	108.62	114.85	65.2	116.23	82.5	113.69	150.11	152.33
EV/Sales	1.13	1.25	1.56	1.77	1.71	1.49	1.43	1.38	1.5	1.28	1.21	1.16	1.11	1.07	1.1
EV/EBITDA	6.42	6.94	8.92	10.04	9.42	8.58	8.61	9.12	10	7.9	8.04	9.79	9.1	7.44	7.28
Price/Earnings	9.49	10.56	15.6	20.16	17.35	14.72	14.41	13.94	15.63	12.39	10.79	15.25	14.72	10.46	9.31
Price/Earnings Average	10.86	9.18	13.13	17.17	18.07	16.95	14.51	14.49	14.82	10.31	11.73	13.1	13.24	11.11	8.16
Price/Earnings High	13.78	10.86	16.09	20.96	21.57	19.34	16.5	16.7	17.19	13.36	13.73	17.13	15.31	14.18	10.52
Price/Earnings Low	7.65	7.94	9.39	13.24	14.69	13.8	12.11	12.99	12.51	5.88	9.67	8.93	10.98	8.75	6.51
Price/Book Value	1.51	1.58	2.28	2.74	2.58	2.11	2.02	1.88	2.15	1.73	1.62	1.58	1.55	1.62	1.73
Price/Book Value Average	1.73	1.37	1.92	2.33	2.69	2.43	2.04	1.95	2.03	1.44	1.76	1.35	1.4	1.72	1.52
Price/Book Value High	2.2	1.63	2.35	2.85	3.21	2.78	2.32	2.25	2.36	1.87	2.06	1.77	1.62	2.2	1.96
Price/Book Value Low	1.22	1.19	1.37	1.8	2.19	1.98	1.7	1.75	1.72	0.82	1.45	0.92	1.16	1.36	1.21
Price/Tangible Book Value	-60.71	-128.21	16.97	14.87	12.35	12.57	8.79	6.69	7.43	4.63	4.79	5	4.66	4.22	4.05
Price/Tangible Book Value Average	-69.52	-111.53	14.29	12.66	12.87	14.47	8.86	6.95	7.05	3.86	5.2	4.3	4.19	4.48	3.55
Price/Tangible Book Value High	-88.2	-131.92	17.51	15.46	15.36	16.51	10.06	8.01	8.17	5	6.09	5.62	4.84	5.72	4.58
Price/Tangible Book Value Low	-48.98	-96.44	10.22	9.76	10.46	11.78	7.39	6.23	5.95	2.2	4.29	2.93	3.47	3.53	2.83
Price/Sales	0.56	0.67	1.08	1.34	1.31	1.06	1.04	1.01	1.12	1.01	0.85	0.77	0.74	0.75	0.8
Price/Sales Average	0.64	0.58	0.91	1.14	1.36	1.22	1.05	1.05	1.06	0.84	0.92	0.66	0.67	0.8	0.7
Price/Sales High	0.81	0.69	1.12	1.39	1.62	1.39	1.19	1.21	1.23	1.09	1.08	0.86	0.77	1.02	0.9
Price/Sales Low	0.45	0.51	0.65	0.88	1.11	0.99	0.88	0.94	0.9	0.48	0.76	0.45	0.55	0.63	0.56
Price/Cash Flow	5.31	5.86	9.01	10.61	11.05	7.75	8.69	8.53	8.85	4.96	12.11	10.34	8.34	5.78	7.44
Price/Cash Flow Average	6.09	5.1	7.58	9.04	11.51	8.93	8.75	8.86	8.39	4.13	13.16	8.89	7.5	6.14	6.52
Price/Cash Flow High	7.72	6.03	9.29	11.03	13.74	10.19	9.95	10.22	9.74	5.34	15.41	11.62	8.67	7.83	8.4
Price/Cash Flow Low	4.29	4.41	5.43	6.97	9.36	7.27	7.3	7.95	7.09	2.35	10.85	6.06	6.22	4.83	5.19
Price/Free Cash Flow Average	4.27	2.43	5.41	5.09	6.33	4.84	5.92	5.44	5.78	3.17	6.78	5.17	4.78	4.3	4.24
Price/Free Cash Flow High	5.42	2.88	6.64	6.21	7.55	5.52	6.73	6.27	6.71	4.1	7.94	6.75	5.53	5.49	5.47
Price/Free Cash Flow Low	3.01	2.1	3.87	3.92	5.14	3.94	4.94	4.88	4.88	1.8	5.59	3.52	3.96	3.38	3.38
EV/Sales Average	1.21	1.16	1.39	1.57	1.77	1.65	1.44	1.42	1.44	1.11	1.28	1.05	1.04	1.11	1
EV/Sales High	1.39	1.27	1.6	1.82	2.03	1.82	1.58	1.58	1.61	1.36	1.44	1.25	1.14	1.33	1.2
EV/Sales Low	1.02	1.08	1.13	1.31	1.51	1.42	1.26	1.31	1.28	0.74	1.12	0.84	0.92	0.94	0.86
EV/EBITDA Average	6.88	6.45	7.95	8.92	9.73	9.5	8.65	9.38	9.61	6.85	8.54	8.87	8.49	7.77	6.63
EV/EBITDA High	7.85	7.05	9.12	10.34	11.17	10.49	9.52	10.44	10.75	8.39	9.58	10.59	9.35	9.32	7.97
EV/EBITDA Low	5.81	6.01	6.47	7.44	8.32	8.19	7.61	8.66	8.51	4.6	7.46	7.1	7.56	6.58	5.68
EV/EBIT Average	9.15	8.57	10.76	12.04	12.84	12.6	11.68	12.99	13.49	9.42	11.87	14.02	12.6	10.47	8.68
EV/EBIT High	10.44	9.36	12.34	13.97	14.76	13.92	12.85	14.46	15.08	11.54	13.33	16.73	13.86	12.56	10.44
EV/EBIT Low	7.72	7.98	8.76	10.04	10.99	10.87	10.27	12	11.94	6.34	10.38	11.21	11.21	8.87	7.45
Last Price	38.86	48.35	81.26	111.26	119.49	106.38	113.35	116.56	143.46	137.5	129.66	140.89	152.44	179.42	218.02
High Price	56.46	49.75	83.83	115.64	148.57	139.77	129.74	139.63	157.79	148.27	165	158.28	158.57	243.25	246.33
Enterprise Value Average	8,207	8,066	10,267	12,904	15,971	16,083	14,953	15,269	16,402	12,795	16,186	14,070	14,806	17,616	17,317
Enterprise Value High	9,370	8,810	11,778	14,969	18,350	17,763	16,444	16,998	18,334	15,671	18,168	16,791	16,292	21,115	20,824
Enterprise Value Low	6,929	7,515	8,358	10,761	13,670	13,870	13,146	14,106	14,523	8,605	14,144	11,250	13,181	14,916	14,848

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Shares Outstanding	97	98	98	99	98	97	94	91	87	85	77	71	67	65	61
Diluted Weighted Avg Shares	99	98	99	101	101	98	96	94	89	86	84	74	70	68	64
Basic Weighted Avg Shares	97	97	98	99	99	97	96	93	89	85	83	73	69	67	64
Revenue per Share	69.55	71.9	75.16	83.03	91.54	100.47	108.83	115.49	128.19	135.89	153.2	183.26	206.03	237.82	273.11
EBITDA per Share	12.27	12.91	13.18	14.64	16.62	17.41	18.07	17.46	19.22	21.97	22.98	21.68	25.15	34.06	41.09
Operating Income per Share	9.23	9.73	9.74	10.84	12.59	13.13	13.38	12.6	13.7	15.97	16.52	13.73	16.96	25.27	31.36
Basic EPS, GAAP	4.1	4.58	5.21	5.52	6.89	7.23	7.87	8.36	9.18	11.1	12.02	9.24	10.35	17.16	23.42
Basic EPS from Cont Ops	4.62	5.05	5.65	6.12	7.6	7.69	8.06	8.55	9.32	11.2	11.97	8.99	10.38	17.48	23.77
Diluted EPS, GAAP	4.04	4.54	5.14	5.42	6.76	7.14	7.81	8.32	9.15	11.03	11.85	9.15	10.24	16.82	23.1
Diluted EPS from Cont Ops	4.56	5.01	5.58	6.02	7.46	7.59	8.01	8.51	9.29	11.13	11.8	8.9	10.26	17.13	23.44
Dividend per Share	0.2	0.6	0.2	0.3	0.4	0.4	0.4	0.4	0.6	0.2	0.8	0.8	0.8	0.8	0.81
Cash Flow per Share	7.31	8.25	9.02	10.48	10.81	13.72	13.04	13.67	16.21	27.75	10.71	13.62	18.29	31.06	29.32
Free Cash Flow per Basic Share	4.07	-0.95	5.23	2.02	1.57	1.84	6.67	4.96	8.82	19.12	0.34	3.58	7.57	16.88	12.97
Cash & Equivalents per Share	0.42	0.24	0.18	0.32	0.62	0.35	0.78	1.13	0.69	14.4	1.4	1.41	1.72	1.89	2.17
Book Value per Share	25.67	30.61	35.71	40.64	46.23	50.33	55.98	62.12	66.86	79.34	80.04	89.37	98.09	110.78	125.72
Tangible Book Value per Share	-0.64	-0.38	4.79	7.48	9.67	8.46	12.89	17.43	19.3	29.67	27.09	28.18	32.74	42.52	53.78

Universal Health Services, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)